FDNA Grants Manchester Centre for Genomic Medicine at Saint Mary’s Hospital, UK as Center of Research Excellence; Advancing Next-Generation Phenotyping for Genetics Evaluations

February 6, 2018

BOSTON–(BUSINESS WIRE)–“Boston-based FDNA today announced that it has awarded a Centers of Research Excellence grant to the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital in the United Kingdom. The grant provides funding to researchers to advance next-generation phenotyping (NGP) and facial analysis technology at luminary sites working on precision medicine.”

Related articles

Dr. Bruno

The Importance of Teaching Face2Gene to Pediatricians

In the world of rare genetic diseases, early diagnosis is often the key to better patient outcomes. However, the diagnostic journey can be long and complex, sometimes taking years before a definitive answer is found. Dr. Bruno Bordest, a Brazilian geneticist who teaches at the Universidade Federal de Mato Grosso, has been working to bridge […]

Continue reading
AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading